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LOW T3 SYNDROME IN CHRONIC HEART FAILURE- PREVALENCE 
AND PROGNOSTIC SIGNIFICANCE 
 
Background: 
Thyroid hormones play an important role in cardiovascular homeostasis. Low 
T3 syndrome is a pattern of illness characterised by Low T3 levels in the 
presence of normal TSH and T4 and is a marker of poor prognosis in patients 
with chronic heart failure. 
Aims and Objectives: 
To estimate the prevalence of low-T3 syndrome in chronic heart failure and to 
assess the role of  free T3 as an adjunct to clinical and functional parameters 
when estimating morbidity and mortality in patients with chronic heart 
failure. 
Methodology: 
100 cases of heart failure with reduced ejection fraction(HFrEF) secondary 
to coronary artery disease were enrolled. Patients were subjected to 2D echo 
and blood investigations including fasting thyroid profile(by 
chemiluminescent immunoassay)Lipid profile, plasma glucose. A 
questionnaire was administered to enquire about their symptoms. Patients 
were followed up monthly over six months . 24 patients were lost to follow up. 
Statistical analysis was carried out over 76 patients, of whom 25 patients 
expired and 51 survived the 6 month period. 
Results: 
 Of the 76 patients. 24 had low T3 values(31.57%).Mean T3  values in the 
alive and dead patients were 130.23 and 75.09 respectively and the relation 
between Low T3 and mortality was statistically ignificant.(P=0.001)In a 
multivariate analysis, Mortality in heart failure was related to Increasing age, 
male sex, higher NYHA class ,lower LV Ejection Fraction and higher LV End 
Diastolic Dimensions(EDD( cox proportional hazard model)Lower T3 values 
were related to increasing age and Lower LV Ejection fraction. 
Other parameters not significantly related to heart failure mortality were 
Obesity, Diabetes, Hypertension, Dyslipidemia, B-blocker use and smoking. 
 
 
Conclusion:  
Low T3 levels is a strong mortality predictor in patients with heart failure and 
might be directly implicated in worsening cardiac function. Further studies  
are needed to explore the therapeutic possibilities of T3 supplementation in 
these  patients. 
